Cargando...

Comparison of the specificities and catalytic activities of hammerhead ribozymes and DNA enzymes with respect to the cleavage of BCR-ABL chimeric L6 (b2a2) mRNA.

With the eventual goal of developing a treatment for chronic myelogenous leukemia (CML), attempts have been made to design hammerhead ribozymes that can specifically cleave BCR-ABL fusion mRNA. In the case of L6 BCR-ABL fusion mRNA (b2a2 type; BCR exon 2 is fused to ABL exon 2), which has no effecti...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Kuwabara, T, Warashina, M, Tanabe, T, Tani, K, Asano, S, Taira, K
Formato: Artigo
Idioma:Inglês
Publicado: 1997
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC146844/
https://ncbi.nlm.nih.gov/pubmed/9224607
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!